𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients

✍ Scribed by Gina Lisignoli; Anna Piacentini; Sandra Cristino; Francesco Grassi; Carola Cavallo; Luca Cattini; Beatrice Tonnarelli; Cristina Manferdini; Andrea Facchini


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
413 KB
Volume
210
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We evaluated the role of CCL20 (MIP‐3α) chemokine in cells directly involved in the remodeling of bone tissue (osteoblasts and osteoclasts) and we confirmed its expression in the subchondral bone tissue of rheumatoid arthritis (RA) patients. The expression of CCL20 and of its receptor CCR6 was evaluated in osteoblasts isolated from bone tissue of post‐traumatic (PT) patients. Functional tests were performed to evaluate osteoblast proliferation and matrix protein modulation. Immunohistochemical analysis for CCR6, CCL20, and RANKL was performed on bone samples from RA patients. The role of CCL20 was then analyzed in osteoclast differentiation. We found that in basal conditions CCR6, but not its ligand CCL20, was highly expressed by osteoblasts. Functional analysis on osteoblasts showed that CCL20 significantly increased cellular proliferation but did not affect matrix protein expression. Pro‐inflammatory cytokines significantly induced the release of CCL20 and RANKL by human osteoblasts but did not modulate CCR6 expression. Increased expression of CCR6, CCL20, and RANKL was confirmed in RA subchondral bone tissue biopsies. We demonstrated that CCL20 was also an earlier inducer of osteoclast differentiation by increasing the number of pre‐osteoclasts, thus favoring cell fusion and MMP‐9 release. Our results add new insight to the important role of the CCL20/CCR6, RANKL system in the bone tissue of RA. The contemporary action of CCL20 on osteoblasts and osteoclasts involved in the maintenance of bone tissue homeostasis demonstrates the important role of this compartment in the evolution of RA, by showing a clear uncoupling between new bone formation and bone resorption. J. Cell. Physiol. 210: 798–806, 2007. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


CCL20/CCR6 chemokine/receptor expression
✍ Gina Lisignoli; Cristina Manferdini; Katia Codeluppi; Anna Piacentini; Francesco 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract Subchondral bone remodeling in osteoarthritis (OA) and rheumatoid arthritis (RA) is mainly characterized by the formation of osteophytes/fibrosis and by the presence of infiltrating cells associated to bone resorption. In this study we analyzed CC (cysteine cysteine motif) chemokine lig

CXCL12 chemokine up-regulates bone resor
✍ Francesco Grassi; Sandra Cristino; Stefania Toneguzzi; Anna Piacentini; Andrea F 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

## Abstract Chemokines are involved in a number of inflammatory pathologies and some of them show a pivotal role in the modulation of osteoclast development. Therefore, we evaluated the role of CXCL12 chemokine on osteoclast differentiation and function and we analyzed its expression on synovial an